
Beijing Xinyun Medical Technology
New Cloud Medical is the leading pain specialist medical association.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
* | $2.7m Valuation: $14.9m | Series B | |
Total Funding | 000k |
Related Content
Beijing Xinyun Medical Technology Co., Ltd., also known as New Cloud Medical, was established in June 2016. The firm is focused on developing and manufacturing medical devices centered around pain management for patients, guided by the needs of pain specialists. Its research and development center is located in Changping District, Beijing, and it operates a 6,000-square-meter GMP standard production base in Jiangsu Province.
The company's product pipeline is diversified across three main categories: minimally invasive interventional surgery, neuromodulation, and percutaneous electrical stimulation. Key products include the NewMild® surgical instrument kit for treating Lumbar Spinal Stenosis and the CalmStim® closed-loop, rechargeable spinal cord stimulation system. Another notable product is the "Smart Cloud Sticker," a wearable smart analgesic device that has received a Class II medical device registration certificate. The company has also developed and manufactures a series of new biomaterials, such as hot/cold therapy hydrogels and conductive hydrogels, which are produced on a large scale and exported to Europe and the United States. Revenue is generated through the sale of these medical devices and materials.
New Cloud Medical has established a collaborative "production-study-research-medical-application" model through deep partnerships with institutions like the Department of Pain Management at the China-Japan Friendship Hospital, Beijing University of Chemical Technology, and the Institute of Electrical Engineering at the Chinese Academy of Sciences. This approach combines the application of new medical hydrogel materials, precision processing, and clinical medicine. The company has secured nearly 100 million RMB in funding from venture capital firms including Zhonglu Capital, Legend Star, and Jinke Junchuang to accelerate its product development and application. Over its history, the company has achieved several milestones, including the completion of its intelligent pain cloud platform in 2017 and receiving multiple awards for innovation and entrepreneurship.
Keywords: pain management, medical devices, chronic pain, minimally invasive surgery, neuromodulation, spinal cord stimulation, percutaneous electrical stimulation, Lumbar Spinal Stenosis, hydrogel, biomaterials, therapeutic devices, surgical instruments, wearable medical devices, medical technology, pain relief, clinical medicine, R&D, medical device manufacturing